All-grade AEs reported in >5% of patients (N = 42)
| All-grade AE . | n (%) . |
|---|---|
| Hematologic toxicity | |
| Neutropenia | 22 (52.4) |
| Febrile neutropenia | 6 (14.3) |
| Anemia | 6 (14.3) |
| Nonhematologic toxicity | |
| Constipation | 18 (42.9) |
| Fatigue | 17 (40.5) |
| Infusion-related reaction | 16 (38.1) |
| Diarrhea | 14 (33.3) |
| Nausea | 13 (31.0) |
| Peripheral sensory neuropathy | 13 (31.0) |
| Cough | 12 (28.6) |
| Alopecia | 10 (23.8) |
| Arthralgia | 9 (21.4) |
| Vomiting | 9 (21.4) |
| Back pain | 8 (19.0) |
| Headache | 8 (19.0) |
| Insomnia | 7 (16.7) |
| Upper respiratory tract infection | 7 (16.7) |
| Abdominal pain | 6 (14.3) |
| Dysgeusia | 6 (14.3) |
| Sinusitis | 6 (14.3) |
| Myalgia | 5 (11.9) |
| Pyrexia | 5 (11.9) |
| Rhinorrhea | 5 (11.9) |
| All-grade AE . | n (%) . |
|---|---|
| Hematologic toxicity | |
| Neutropenia | 22 (52.4) |
| Febrile neutropenia | 6 (14.3) |
| Anemia | 6 (14.3) |
| Nonhematologic toxicity | |
| Constipation | 18 (42.9) |
| Fatigue | 17 (40.5) |
| Infusion-related reaction | 16 (38.1) |
| Diarrhea | 14 (33.3) |
| Nausea | 13 (31.0) |
| Peripheral sensory neuropathy | 13 (31.0) |
| Cough | 12 (28.6) |
| Alopecia | 10 (23.8) |
| Arthralgia | 9 (21.4) |
| Vomiting | 9 (21.4) |
| Back pain | 8 (19.0) |
| Headache | 8 (19.0) |
| Insomnia | 7 (16.7) |
| Upper respiratory tract infection | 7 (16.7) |
| Abdominal pain | 6 (14.3) |
| Dysgeusia | 6 (14.3) |
| Sinusitis | 6 (14.3) |
| Myalgia | 5 (11.9) |
| Pyrexia | 5 (11.9) |
| Rhinorrhea | 5 (11.9) |